The FDA approved the first-ever drug for female sexual dysfunction. The Raleigh-based company, Sprout, is behind the libido pill.
This morning, Valeant Pharmaceuticals announced it is buying Sprout for $1 billion. Some hail the FDA approval as a victory for gender equality but critics say the many risky side effects outweigh the benefits.
Host Frank Stasio talks with Triangle Business Journal reporter Jason deBruyn.